New shot tested to halt damage in serious kidney diseases
Disease control
Recruiting now
This study is testing an investigational drug called atacicept for several autoimmune kidney diseases, including IgA Nephropathy and Focal Segmental Glomerulosclerosis. It aims to see if weekly injections are safe and can reduce protein in the urine and help preserve kidney funct…
Phase: PHASE2 • Sponsor: Vera Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC